Claire Mulot
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Circulating Tumor DNA Dynamics and Clinical Outcomes in Patients with Advanced Colorectal Cancer Treated with Cetuximab-Based Induction and Maintenance Treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2025
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 18, 2025
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 17, 2025
Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 26, 2025
Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 10, 2025
Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 31, 2025
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer.
Journal: Frontiers in genetics
Published: December 15, 2024
Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials.
Journal: ESMO gastrointestinal oncology
Published: November 07, 2024
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.
Journal: Oncoimmunology
Published: July 26, 2023
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Journal: Breast cancer research : BCR
Published: April 05, 2023
Last Updated: 09/26/2026